Silvan Tuerkcan Analyst PerformanceSenior Research Analyst at Citizens JmpSilvan Tuerkcan is a stock analyst at Citizens Jmp focused in the medical sector, covering 18 publicly traded companies. Over the past year, Silvan Tuerkcan has issued 34 stock ratings, including buy and hold recommendations. While full access to Silvan Tuerkcan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Silvan Tuerkcan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings64 Last 7 YearsBuy Recommendations85.00% 51 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution60RatingsDistribution of strong buy, buy, hold, and sell ratings by Silvan Tuerkcan.RatingPercentageCount Strong Buy0.0%0 ratings Buy85.0%51 ratings Hold15.0%9 ratings Sell0.0%0 ratingsOut of 60 total stock ratings issued by Silvan Tuerkcan at Citizens Jmp, the majority (85.0%) have been Buy recommendations, followed by 15.0% Hold.Best & Worst CallsBest Call000000.0%TERNApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TSHASep 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ88.9% of companies on NASDAQ16 companiesNYSE11.1% of companies on NYSE2 companiesSilvan Tuerkcan, an analyst at Citizens Jmp, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies88.9%Manufacturing2 companies11.1%Silvan Tuerkcan of Citizens Jmp specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE13 companies72.2%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2 companies11.1%MED - GENERIC DRG1 company5.6%MEDICAL INFO SYS1 company5.6%PHARMACEUTICAL PREPARATIONS1 company5.6% About Silvan TuerkcanBiophysicist; Equity research in biotechnology; Data scientist with expertise in ML and AI I am a equity research analyst of smid-cap biotechnology companies. We focus on pre-revenue companies that have differentiated assets that target unmet needs. I apply Bayesian statistics and other machine learning techniques to for automated decision making. I use a combination of statistics, model discrimination, and visualization techniques to extract relevant information. Beyond scientific data, I apply these techniques to help companies use their data in the fields of social media applications and drug discovery. My research interests lie in how small biological and statistical differences in different sub-populations within a cells can cause disease. My academic research focused on microscopy techniques, image analysis, and statistical methods to study the metabolism of cancer. My entrepreneurial interests lie in the field of digital health and biotechnology for clinical use.Follow on LinkedIn Silvan Tuerkcan's Ratings History at Citizens Jmp Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTERNTerns Pharmaceuticals3/26/2026Downgrade$52.86Hold$0.0000.00% ROICRSPCRISPR Therapeutics12/23/2025Reiterated Rating$57.91$86.00Market Outperform$0.0000.00% ROITERNTerns Pharmaceuticals12/11/2025Boost Price Target$44.61$57.00Market Outperform$0.0000.00% ROITERNTerns Pharmaceuticals11/26/2025Set Price Target$29.34$35.00$0.0000.00% ROITERNTerns Pharmaceuticals11/26/2025Boost Price Target$29.34$35.00Market Outperform$0.0000.00% ROINUVBNuvation Bio11/20/2025Boost Price Target$7.15$10.00Market Outperform$0.0000.00% ROIENGNenGene11/12/2025Boost Price Target$9.27$21.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics11/7/2025Lower Price Target$12.32$21.00Market Outperform$0.0000.00% ROIEXELExelixis11/5/2025Reiterated Rating$37.90$36.00Market Perform$0.0000.00% ROITSHATaysha Gene Therapies11/5/2025Boost Price Target$4.27$8.00Market Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BNTCBenitec Biopharma11/4/2025Set Price Target$15.86$22.00$0.0000.00% ROINUVBNuvation Bio11/4/2025Boost Price Target$5.17$8.00Market Outperform$0.0000.00% ROIBNTCBenitec Biopharma11/4/2025Boost Price Target$15.86$22.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Lower Price Target$14.79$29.00Market Outperform$0.0000.00% ROITERNTerns Pharmaceuticals10/23/2025Lower Price Target$7.91$15.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics10/6/2025Upgrade$19.96$33.00Outperform$0.0000.00% ROIBNTCBenitec Biopharma9/24/2025Reiterated Rating$13.22$20.00Market Outperform$0.0000.00% ROIJSPRJasper Therapeutics9/22/2025Lower Price Target$2.51$6.00Market Outperform$0.0000.00% ROINTLAIntellia Therapeutics9/19/2025Reiterated Rating$16.11Market Perform$0.0000.00% ROIPHRPhreesia9/8/2025Boost Price Target$27.93$34.00Market Outperform$0.0000.00% ROIEXELExelixis7/29/2025Reiterated Rating$37.59$50.00Market Outperform$0.0000.00% ROIJSPRJasper Therapeutics7/8/2025Lower Price Target$3.19$12.00Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics6/27/2025Reiterated Rating$46.70$86.00Market Outperform$0.0000.00% ROINUVBNuvation Bio6/25/2025Reiterated Rating$1.99$6.00Market Outperform$0.0000.00% ROIEXELExelixis6/23/2025Boost Price Target$40.37$50.00Market Outperform$0.0000.00% ROIELEVElevation Oncology6/10/2025Reiterated Rating$0.38Market Perform$0.0000.00% ROISLDBSolid Biosciences6/6/2025Reiterated Rating$4.57$15.00Market Outperform$0.0000.00% ROINUVBNuvation Bio6/2/2025Reiterated Rating$2.31$6.00Market Outperform$0.0000.00% ROITSHATaysha Gene Therapies5/29/2025Boost Price Target$2.82$6.00Market Outperform$0.0000.00% ROICRSPCRISPR Therapeutics5/21/2025Reiterated Rating$39.25$86.00Market Outperform$0.0000.00% ROIPRMEPrime Medicine5/20/2025Lower Price Target$1.26$6.00Market Outperform$0.0000.00% ROIFHTXFoghorn Therapeutics5/15/2025Reiterated Rating$4.18$9.00Market Outperform$0.0000.00% ROIBNTCBenitec Biopharma5/15/2025Reiterated Rating$13.30$20.00Market Outperform$0.0000.00% ROIVORVor Biopharma5/9/2025Reiterated Rating$2.76$120.00Market Perform$0.0000.00% ROIFHTXFoghorn Therapeutics4/30/2025Reiterated Rating$4.16$9.00Market Outperform$0.0000.00% ROITSHATaysha Gene Therapies4/28/2025Reiterated Rating$1.84$5.00Market Outperform$0.0000.00% ROIFHTXFoghorn Therapeutics4/23/2025Initiated Coverage$4.24$9.00Market Outperform$0.0000.00% ROINUVBNuvation Bio4/23/2025Initiated Coverage$2.07$6.00Market Outperform$0.0000.00% ROITERNTerns Pharmaceuticals4/21/2025Reiterated Rating$2.80$20.00Market Outperform$00.0000.00% ROIEXELExelixis4/17/2025Reiterated Rating$36.30$41.00Market Outperform$00.0000.00% ROIBNTCBenitec Biopharma4/10/2025Boost Price Target$11.64$20.00Market Outperform$00.0000.00% ROICRSPCRISPR Therapeutics2/13/2025Reiterated Rating$42.61$86.00Market Outperform$00.0000.00% ROIEXELExelixis1/23/2025Reiterated Rating$32.70$41.00Market Outperform$00.0000.00% ROIEXELExelixis1/15/2025Boost Price Target$36.78$41.00Market Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerRaymond James FinancialStifel NicolausBMO Capital Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.